Latest News about GSK
Recent news which mentions GSK
Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments
January 25, 2022
From MarketWatch
FDA Clears Lyell Immunopharma' LYL132 Trial For Solid Tumors
January 24, 2022
From Benzinga
Activist investor Nelson Peltz acquires stake in Unilever
January 23, 2022
From MarketWatch
Activist Investor Nelson Peltz's Fund Buys Stake In Unilever: FT
January 23, 2022
From Benzinga
Why Jim Cramer Like NextEra Energy And Lincoln Electric?
January 21, 2022
From Benzinga
South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing
January 20, 2022
From MarketWatch
Why Unilever Stock Rose as Much as 10% Today
January 19, 2022
From Motley Fool
3 Under-the-Radar COVID Stocks
January 19, 2022
From Motley Fool
From Motley Fool
23andMe Pivoting To Clinical Research: Could That Lead To A Turnaround For The Stock?
January 18, 2022
From Benzinga
2 Best COVID-19 Growth Stocks to Own in 2022
January 17, 2022
From Motley Fool
From MarketWatch
GSK Spurns $68.4B Bid From Unilever For Its Consumer Healthcare Business, Opts to Spin-off The Unit
January 15, 2022
From Benzinga
3 Top Biotech Stocks to Buy Right Now
January 15, 2022
From Motley Fool
Watch for Continued Gains in Shares of GlaxoSmithKline PLC (GSK)
January 14, 2022
Tickers
GSK
From Benzinga
From Benzinga
2 Top Healthcare Stocks to Buy Right Now
January 14, 2022
From Motley Fool
GSK, Vir Biotech File For Emergency Use Nod For Intramuscular Sotrovimab For COVID-19
January 13, 2022
From Benzinga
Adagio's COVID-19 Antibody Has Neutralizing Activity Comparable To Other Antibodies
January 13, 2022
From Benzinga
From Benzinga
From MarketWatch
CureVac Outlines Upcoming Catalysts For Vaccine Programs
January 10, 2022
From Benzinga
My 3 Top Biotech Stock Picks for 2022
January 09, 2022
From Motley Fool
The 3 Smartest Tech Stocks to Buy in 2022 and Beyond
January 05, 2022
From Motley Fool
Happy new year? Drug prices rising as 2022 begins
January 05, 2022
From MarketWatch
Why iTeos Therapeutics Topped the Market Today
January 03, 2022
From Motley Fool
Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
December 29, 2021
From Benzinga
Johnson & Johnson Stock: Bull vs. Bear
December 27, 2021
From Motley Fool
From Benzinga
My 3 Favorite Under-the-Radar Healthcare Stocks for 2022
December 21, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.